Latest short bowel syndrome Stories
Round led jointly by OrbiMed, Pontifax and Jacobs Investment Company.
OxThera AB announced today that its product Oxabact® has been granted an Orphan Drug Designation in the European Union for treatment of Short Bowel Syndrome (SBS) STOCKHOLM, September 23,
IT GUTS BETTER, will officially kick-off on Tuesday, December 10, 2013.
Research being presented at Digestive Disease WeekÂ® (DDW) shows that patients taking a blood thinner (clopidogrel) after having polyps removed during colonoscopy were at relatively low risk of bleeding.
DETROIT, Sept. 22 /PRNewswire/ -- The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital. The 11-hour surgery was performed on August 21 and 22.
Young people with inflammatory bowel diseases have low bone mass and poor bone architecture compared to healthy people of the same age, placing them at increased risk of fracture.
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today presented positive one-year data from a Phase 3-extension study of GATTEX(TM) (teduglutide), an investigational product for patients dependent upon parenteral nutrition due to short bowel syndrome (SBS).
NPS Pharmaceuticals, Inc. Susan Mesco, 908-450-5516 email@example.com Logo: http://www.npsp.com NPS Pharmaceuticals, Inc.